Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2000 | 12-1999 | 09-1999 | 06-1999 | 03-1999 | |
| Gross Profit | 2,280 | 2,050 | 1,210 | 1,240 | 1,150 |
| Operating Expenses | 1,760 | 1,290 | 1,030 | 1,350 | 1,300 |
| Operating Income | -1,760 | -1,290 | -1,030 | -1,350 | -1,300 |
| Pre-tax Income | -1,760 | -1,290 | -1,030 | -1,350 | -1,300 |
| Net Income Continuous | -1,760 | -1,290 | -1,030 | -1,350 | -1,300 |
| Net Income | $-1,760 | $-1,290 | $-1,030 | $-1,350 | $-1,300 |
| EBITDA(a) | $-1,730 | $-1,260 | $-1,000 | $-1,320 | $-1,280 |